Prof Kelly Chibale discusses stemming Africa's brain drain
Prof Kelly Chibale published an article in the Medicine Maker on how African Pharma has a promising role in changing the afro-pessimistic sentiment, so that we may begin to attract and retain skilled African scientists.
"African pharma has a promising future. More than ever, companies who take risks are establishing themselves as serious partners for international organizations. H3D recently partnered with the African Academy of Sciences, Bill and Melinda Gates Foundation, and the Medicines for Malaria Venture on “Grand Challenges Africa,” a scheme that encourages innovation to address the continent’s health and development needs. The project aims to expand the drug discovery community across Africa by, amongst other things, linking African academic institutions with partners from big pharma – crucially important for the future of our industry. The more R&D centers we have with advanced capabilities and robust infrastructure, the greater our impact. It won’t be easy to achieve, but it is within our reach."
The full article is available here.
Article credit: The Medicine Maker